article
14 June 2019 | By Sheraz Gul (Head of Drug Discovery at the Fraunhofer Institute for Molecular Biology and Applied Ecology)
Progressing drug discovery projects to a stage that attracts commercial interest is a challenging endeavour, evidenced by the fact that only a small proportion of drug discovery projects are successfully progressed to such a stage. A major cause of this is the lack of comprehensive profiling of compounds prior to…